Navigation Links
Will Obama's Stem Cell Announcement Doom Promising Adult Stem Cell Research?
Date:3/12/2009

- Stem Cell Business Community Suggests Adult Stem Cell Advances Could Be Lost as Embryonic Researchers Compete for Funding

SAN CLEMENTE, Calif., March 12 /PRNewswire/ -- Adult Stem Cell scientists and businesses are concerned that President Obama's executive order repealing restrictions on Embryonic Stem Cell research will have the unintended consequence of diverting attention and resources away from the promising Adult Stem Cell scientific advances.

STEMTech HealthSciences is a leading company in the field of Stem Cell Nutrition and its chief executive officer is speaking out to create awareness of Adult Stem Cell science's need for continued support and resources. Adult Stem Cells are naturally created by a person's own body while Embryonic Stem Cells are extracted from embryos.

"The amazing advances over the past few years in Adult Stem Cell science, including the Nobel Prize winning advances that led to the discovery that Adult Stem Cells travel to tissues and organs needing renewal and become cells of these organs and tissues, are at risk of being eclipsed because of the media and business furor over Embryonic Stem Cells" said STEMTech CEO Ray Carter.

According to Carter, Embryonic Stem Cell research is a multi-billion dollar industry with Wall Street, the media and now the U.S. government joining in to create visibility and mass funding. Meanwhile, the scientific progress made by companies such as STEMTech which owns the rights to the only patented product proven to enhance Adult Stem Cell release in a person's own body goes relatively unnoticed.

While not a mediagenic billion dollar player however, STEMTech has grown into 8 countries since 2006 with its Stem Cell Nutrition product line which supports healthy Adult Stem Cell physiology.

Christian Drapeau, author of The Stem Cell Theory of Renewal (March 2009, Sutton Hart www.suttonhart.com) and pioneer of the Stem Cell Nutrition field, explains the StemEnhance(R) value proposition that "a natural, mild long term increase in the body's level of circulating Adult Stem Cells delivers substantial wellness benefits".

According to Christian Drapeau, who serves as STEMTech's chief science officer, Adult Stem Cells have the greater potential for human wellness and he echoes Carter's concern that President Obama's removing restrictions Embryonic Stem Cell research could divert critical resources away from Adult Stem Cell research.

Media Contact: Maggie Jessup maggie@platformstrategy.com


'/>"/>
SOURCE STEMTech HealthSciences
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. National Health High Risk Pool Association Available to Discuss Role of Pools in President Elect Obamas Health Care Reform Plans
2. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
3. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
4. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Todays 2008 Medicare Part B Premium Announcement is Not Good News
7. Statement Regarding Microsofts Announcement of New Services to Help People Store Their Health Information Online
8. Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement
9. CHPA Lends Support to FDAs Announcement Against Use of Oral, Over-the-Counter Cough and Cold Medicines in Children Under Two
10. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
11. AHIP Statement on New York Attorney Generals Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... ... copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie ... are thrilled to partner with Cupron® to provide customers with a game changing ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on Kickstarter , ... be available at a discounted crowdfunding price on Indiegogo . , “Along with ... also wanted to bring a fidget toy to the market that was made of ...
(Date:5/26/2017)... ... 2017 , ... Silver Birch of Hammond, a new assisted lifestyle community, has ... acres of land at 5620 Sohl Avenue in Hammond, serves older adults who need ... studio and one-bedroom apartments. Each of the private apartments at Silver Birch features a ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Dr. Alex Rabinovich, ... to announce a new, informational blog post on insurance options. If a Bay Area ... plans may help save time and money. Visiting an in-network provider for a second ...
(Date:5/26/2017)... ... 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of Bob ... is the creation of published authors, Bob and Margaret Massey. Bob Massey is small ... "panther quick and leather tough." His love for others is apparent in all of ...
Breaking Medicine News(10 mins):
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, the ... announces the launch of a new website ... results of a clinical study that showed surprising ... with Gene-Eden-VIR/Novirin in individuals suffering from HPV warts, ... that there are no other treatments that clear ...
(Date:5/18/2017)... WHIPPANY, N.J. , May 17, 2017  Bayer ... growing oncology portfolio will be presented at the 53 ... Clinical Oncology (ASCO), taking place June 2-6 in ... being presented at ASCO span prostate, colorectal, liver and ... subgroup analysis from the Phase II CHRONOS-1 trial of ...
Breaking Medicine Technology: